Skip Nav Destination
1-2 of 2
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial
Tait D. Shanafelt, MD, Victoria Wang, Neil E. Kay, MD, Curtis A. Hanson, MD, Susan M. O'Brien, MD, Jacqueline C. Barrientos, MD MS, Diane F Jelinek, PhD, Esteban Braggio, PhD, Jose F. Leis, MD PhD, Cong Christina Zhang, Steven Coutre, MD, Paul M. Barr, MD, Amanda F Cashen, MD, Anthony R. Mato, MD MSCE, Avina Singh, MD, Michael P. Mullane, MD, Richard F. Little, MD MPH, Harry P. Erba, MD PhD, Richard M. Stone, MD, Mark Litzow, MD, Martin S. Tallman, MD
Blood (2019) 134 (Supplement_1): 33.
Michael A Thompson, MD PhD, Martin K Oaks, PhD, John O Richards, PhD, Maharaj Singh, PhD, Thomas S Smith, BS, Karen M Michel, BS, Andinet W Alemu, MD, Michael P. Mullane, MD, Husam S Tarawneh, MD, Angela M Kraut, Kayla J Hamm, Carla Fuentes
Blood (2016) 128 (22): 5607.